Completed

PINQLEPredictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis: Prospective Observational Multicenter Study

What is being collected

Data Collection

Collected at a single point in time - Cross-sectional

Who is being recruted

Colitis+5

+ Colitis, Ulcerative

+ Colonic Diseases

From 18 to 80 Years

+6 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.

Observational

Study Start: January 2016

See protocol details

Summary

Principal SponsorKyungpook National University Hospital

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2016

Actual date on which the first participant was enrolled.

The purpose of this study is to determine whether fecal calprotectin, fecal immunochemical test, and Rome III criteria for irritable bowel syndrome (IBS) can predict mucosal healing in patients with quiescent ulcerative colitis (UC).

Official TitlePredictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis: Prospective Observational Multicenter Study

NCT02640391

Principal SponsorKyungpook National University Hospital

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

127 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

ColitisColitis, UlcerativeColonic DiseasesDigestive System DiseasesGastroenteritisGastrointestinal DiseasesIntestinal DiseasesInflammatory Bowel Diseases

Criteria

3 inclusion criteria required to participate

Patients with ulcerative colitis who have no change of medication for at least 6 months

Patients with ulcerative colitis who are in remission (Mayo score <3)

Patients with ulcerative colitis who will undergo colonoscopy for surveillance or mucosal healing check-up

3 exclusion criteria prevent from participating

Patients who refuse to participate

Patients who have a history of colectomy

Patients who have instinal stricture or perforation

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Keimyung University Dongsan Medical Center

Daegu, South KoreaOpen Keimyung University Dongsan Medical Center in Google Maps

CompletedOne Study Center